Sevoflurane

   
Google
 
Web NewDrugInformation.com

Sevoflurane


Drug - Sevoflurane
The trade name of the product as shown on the labeling.

Dosage - LIQUID; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sevoflurane
Multiple ingredients are in alphabetical order.

Strength - 100%
The potency of the active ingredient(s), Sevoflurane. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Sevoflurane. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075895
The FDA assigned number to Sevoflurane. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sevoflurane. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AN
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 2, 2002
The date Sevoflurane was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sevoflurane. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Sevoflurane is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp
The full name of the firm holding legal responsibility for the new application of Sevoflurane.

Sevoflurane